Likewise, at HMDS JAK2 mutations are used to diagnose chronic MPNs; but the further breakdown into polycythaemia vera (PV) and essential thrombocythaemia (ET) requires access to blood count data and other clinical parameters, and these procedures have only recently been routinely incorporated. Here, JAK2 is linked to essential thrombocythemia.